Related Experiment Video
Updated: Jan 22, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
LNC CRYBG3 inhibits tumor growth by inducing M phase arrest
Weidong Mao1,2, Ziyang Guo1, Yingchu Dai1
1State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, China.
Abstract:
Long noncoding RNAs (lncRNAs) are usually associated with tumor development and progression and some of them are dysregulated in various human cancers. The mechanisms underlying their dysregulation are worth further study. Here, we demonstrate that the expression level of LNC CRYBG3 is correlated with 1501 aberrantly expressed proteins in A549 cells (non-small cell lung cancer (NSCLC) cells). LNC CRYBG3 overexpression results in M phase arrest and promoted cell death, whereas LNC CRYBG3 knockdown did not elicit the opposite effects. The overexpression of LNC CRYBG3 inhibits cell proliferation both in vitro and in vivo. Moreover, it upregulates the expression of cyclin B1 and the phosphorylation of H3, whereas it inhibited the expression of cyclin-dependent kinase 6 and cyclin D1. Taken together, these findings suggest that LNC CRYBG3 regulates the cell cycle process of A549 cells, suggesting its potential application for the treatment of this disease.
Insights
Long noncoding RNA CRYBG3 (LNC CRYBG3) overexpression halts cell division and promotes cancer cell death in non-small cell lung cancer. This lncRNA shows potential for future cancer therapies.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long noncoding RNAs (lncRNAs) play roles in cancer development and progression.
- Dysregulation of specific lncRNAs is observed in various human cancers.
- Understanding the mechanisms of lncRNA dysregulation is crucial for cancer research.
Purpose of the Study:
- To investigate the role of LNC CRYBG3 in non-small cell lung cancer (NSCLC).
- To explore the functional impact of LNC CRYBG3 expression on A549 lung cancer cells.
- To identify potential therapeutic applications of LNC CRYBG3 in NSCLC treatment.
Main Methods:
- Correlation analysis between LNC CRYBG3 expression and protein levels in A549 cells.
- Assessment of cell cycle progression (M phase arrest) and cell death upon LNC CRYBG3 overexpression.
- Evaluation of cell proliferation in vitro and in vivo.
- Analysis of key cell cycle regulatory proteins (cyclin B1, H3 phosphorylation, cyclin-dependent kinase 6, cyclin D1).
Main Results:
- LNC CRYBG3 expression correlated with 1501 aberrantly expressed proteins in A549 NSCLC cells.
- Overexpression of LNC CRYBG3 induced M phase arrest and promoted cell death.
- LNC CRYBG3 overexpression inhibited NSCLC cell proliferation both in vitro and in vivo.
- LNC CRYBG3 modulated the expression of cell cycle regulators, including upregulation of cyclin B1 and H3 phosphorylation, and downregulation of CDK6 and cyclin D1.
Conclusions:
- LNC CRYBG3 acts as a regulator of the cell cycle in A549 NSCLC cells.
- The findings suggest LNC CRYBG3's potential as a therapeutic target for NSCLC.
- Further research into LNC CRYBG3 mechanisms could lead to novel cancer treatment strategies.
Related Concept Videos
Feedback Inhibition
Phase Diagrams
Enzyme Inhibition
Phase Transitions
Population Growth
Inductance: Single-Phase And Three-Phase Line
Single-Phase Two-Wire Line:
A single-phase line consists of two solid cylindrical conductors, denoted as x and y. Each conductor carries phasor currents ix and iy, respectively. Given that the sum of these currents is...

